Liljenfeldt, Lina <br/><br/>
Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand.  [electronic resource] 

 -  Cancer immunology, immunotherapy : CII  Mar 2014 
 - 273-82 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-0851 
<br/><br/><label>Standard No.: </label>10.1007/s00262-013-1507-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenoviridae<br/>Animals<br/>Antibody Formation--drug effects<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Apoptosis--drug effects<br/>CD40 Ligand--genetics<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>Combined Modality Therapy<br/>Fas Ligand Protein--metabolism<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymphocyte Activation--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Nude<br/>Recombinant Proteins--genetics<br/>T-Lymphocytes--drug effects<br/>Urinary Bladder Neoplasms--drug therapy<br/>fas Receptor--metabolism